Jim Cramer believes forced selling is creating opportunities, but investors should resist buying too early.
CLX's Cleaning gains and innovation support Household strength, but Litter and Food weakness may limit broader growth.
It's the right time to jump in on dividend stocks. Clorox, Pfizer, Verizon and Comcast are some of the names to consider.
Shares in The Clorox Company continue to struggle, with YTD losses of over 7% adding to its losses of over 25% in the past year. The declines come as the cleaning-products maker is contending with declining sales and decreasing profitability. While the challenges are real, I believe CLX can overcome them and return to positive growth.
Clorox managed to keep its sales flat YoY and improve its EPS slightly, despite contracting gross margins, due to elevated energy prices. Based on a dividend discount model, assuming 2% growth in perpetuity and a 7.7% required rate of return, the upside from the current price levels seems to be limited. For these reasons, I upgrade CLX to hold.
The Clorox Company (CLX) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
Clorox Chief Executive Officer Linda Rendle is stepping down for health reasons after more than 20 years at the company.
Investors love dividend stocks, especially the blue-chip variety, because they offer a significant income stream and have massive total return potential.
Companies that have raised dividends for shareholders for 50 years or more are the kinds of investments passive income investors need to own.
Clorox (NYSE: CLX | CLX Price Prediction) spent the past 10 years doing what consumer staples are supposed to do: pay reliably, raise dividends annually, and grind through cycles.
Clorox (CLX) is rated a 'Buy' at $87.1, with a 37% undervaluation and 44.7% potential total return, supported by a robust dividend yield and conservative growth outlook. Short-term headwinds—ERP transition, supply chain costs, and high oil prices—are expected to ease, while the GOJO acquisition and international expansion underpin long-term growth. Dividend sustainability is challenged by an 89% payout ratio in FY26, but gradual EPS growth and minor dividend hikes should normalize payout to 60-65% over five years.
Clorox tops Q3 EPS estimates on cost cuts despite flat sales. It trims the FY26 outlook after GOJO close and bigger margin pressure.